SCHEMBL6833241

SCHEMBL6833241

N#Cc1ccc(NC(=O)c2cncc(-c3ccccn3)c2)c(C(=O)O)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 2/20 0.47
KMT2A Q03164 3/20 0.46
MEN1 O00255 2/20 0.46
KDM4E B2RXH2 1/20 0.46
HTT P42858 1/20 0.46
ALDH1A1 P00352 1/20 0.46
GAK O14976 1/20 0.45
STK16 O75716 1/20 0.45
PIM1 P11309 1/20 0.45
AXL P30530 1/20 0.45
NEK2 P51955 1/20 0.45
STK3 Q13188 1/20 0.45
STK11 Q15831 1/20 0.45
AAK1 Q2M2I8 1/20 0.45
BMP2K Q9NSY1 1/20 0.45
TNIK Q9UKE5 1/20 0.45
KCNH2 Q12809 1/20 0.44
SCN10A Q9Y5Y9 1/20 0.44
PPARG P37231 2/20 0.44
ALB P02768 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6833253 0.89 GAK (0.46) KMT2AALDH1A1GAKSTK16PIM1
SCHEMBL6833755 0.87 KCNH2 (0.55) KMT2AKDM4EHTTALDH1A1GAK
SCHEMBL6830011 0.82 SERPINE1 (0.49) KMT2AMEN1ALDH1A1GAKSTK16
SCHEMBL6835793 0.82 KCNH2 (0.49) MAPK14KMT2AMEN1ALDH1A1KCNH2
SCHEMBL6835718 0.82 SERPINE1 (0.50) HTTALDH1A1GAKSTK16PIM1
SCHEMBL6834140 0.81 SCN10A (0.54) KMT2AMEN1GAKSTK16PIM1
SCHEMBL6833871 0.80 MAPT (0.52) KMT2AMEN1HTTALDH1A1KCNH2
SCHEMBL6353963 0.80 KMT2A (0.62) KMT2AMEN1HTTALDH1A1ALB
SCHEMBL6834009 0.80 CTSA (0.47) KMT2AKDM4EALDH1A1KCNH2SCN10A
SCHEMBL6833859 0.79 GRM4 (0.61) KMT2AKDM4EHTTALDH1A1GRM4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040110802-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040110802-A1 Antibacterial benzoic acid derivatives GABRD, GABBR1, GABRA1 MAPK14 2632/4885KMT2A 2853/4885MEN1 4132/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.